Sigaard Jarl Voss Andersen, Henneberg Nanna Celina, Schacksen Cathrine Skov, Kronborg Sissel Højsted, Petrini Laura, Kidholm Kristian, Birgisdóttir Una Rósa, Spindler Helle, Dinesen Birthe
Hospital of Southwest Jutland, University Hospital of Southern Denmark, Esbjerg, Denmark.
Laboratory for Welfare Technology-Digital Health & Rehabilitation, ExerciseTech, Department of Health Science and Technology, Aalborg University, Aalborg, Denmark.
JMIR Res Protoc. 2024 Apr 2;13:e49946. doi: 10.2196/49946.
The World Health Organization defines end-of-life palliative care as "prevention and relief of suffering, by means of early identification and impeccable assessment and treatment of pain and other problems, physical, psychosocial and spiritual." Over 20 million people worldwide are in need of palliative care. In Denmark, palliative care is given at a general and a specialist level. The general level comprises health care professionals (HCPs) who do not perform palliative care full-time. The specialist level comprises specialized palliative care (SPC), where HCPs perform palliative care full-time. In total, 20%-30% of patients who need palliative care are referred to SPC. Challenges with SPC include a short time span from referral to end of life, patients who are very ill and may therefore find it hard to travel to an outpatient clinic, and the SPC unit having a relatively small staff. The need for SPC is expected to rise, as the number of patients dying from terminal diseases is increasing. Telehealth has been successfully implemented in different home care settings, including palliative care.
The aim of the study is to present the research design of the clinical testing of a telepalliation program by the use of a digital platform for patients in palliative care and their relatives.
The telepalliation program will be conducted as a multimethod randomized controlled trial. The intervention group will follow the telepalliation program, while the control group will follow the traditional standard of care program for palliative care. The primary outcome of the study is increased quality of life. Secondary outcomes include enhanced sense of security; reduced experience of pain; satisfactory experiences of patients and relatives with the TelePal platform and degree of satisfaction in being a part of the program; experiences with the use of the TelePal platform on the part of HCPs and the professionals' experiences of being a part of the program; the use of a cross-sector communication platform and the telepalliation program by patients, relatives, and HCPs; and the projected lower cost of health care services. These outcomes will be assessed using questionnaires, data generated by digital technologies, and semistructured interviews.
The collection of data began in May 2021 and will be completed in August 2024. The results of the study will be published in peer-reviewed journals and presented at international conferences. Results from the telepalliation program are expected to be published by fall 2024.
The expected outcomes of the study are increased quality of life and increased sense of security. We also expect that the study will have a clinical impact on future telepalliation for those patients who are referred to a palliative team.
ClinicalTrials.gov NCT04995848; https://clinicaltrials.gov/study/NCT04995848.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/49946.
世界卫生组织将临终姑息治疗定义为“通过早期识别以及对疼痛和其他身体、心理社会及精神问题进行完善的评估与治疗,预防和缓解痛苦”。全球有超过2000万人需要姑息治疗。在丹麦,姑息治疗分为普通和专科两个层面。普通层面包括并非全职从事姑息治疗的医护人员。专科层面包括专科姑息治疗(SPC),其中医护人员全职从事姑息治疗。总体而言,20% - 30%需要姑息治疗的患者会被转介至专科姑息治疗。专科姑息治疗面临的挑战包括从转介到生命终结的时间跨度短、患者病情严重可能难以前往门诊,以及专科姑息治疗单位的工作人员相对较少。随着死于绝症的患者数量增加,对专科姑息治疗的需求预计将会上升。远程医疗已在包括姑息治疗在内的不同家庭护理环境中成功实施。
本研究的目的是介绍一项针对姑息治疗患者及其亲属使用数字平台进行远程姑息治疗项目临床试验的研究设计。
远程姑息治疗项目将作为一项多方法随机对照试验开展。干预组将遵循远程姑息治疗项目,而对照组将遵循传统的姑息治疗标准护理项目。本研究的主要结局是生活质量提高。次要结局包括安全感增强;疼痛体验减轻;患者及其亲属对远程姑息治疗平台(TelePal平台)的满意体验以及参与该项目的满意度;医护人员对TelePal平台的使用体验以及专业人员参与该项目的体验;患者、亲属和医护人员对跨部门沟通平台和远程姑息治疗项目的使用情况;以及预计医疗保健服务成本降低。这些结局将通过问卷调查、数字技术生成的数据以及半结构化访谈进行评估。
数据收集于2021年5月开始,将于2024年8月完成。本研究结果将在同行评审期刊上发表,并在国际会议上展示。远程姑息治疗项目的结果预计将于2024年秋季公布。
本研究的预期结果是生活质量提高和安全感增强。我们还预计该研究将对未来转介至姑息治疗团队的患者的远程姑息治疗产生临床影响。
ClinicalTrials.gov NCT04995848;https://clinicaltrials.gov/study/NCT04995848。
国际注册报告标识符(IRRID):DERR1-10.2196/49946。